Literature DB >> 21054081

Noninvasive fluorescence monitoring of protoporphyrin IX production and clinical outcomes in actinic keratoses following short-contact application of 5-aminolevulinate.

Christine B Warren1, Sara Lohser, Lauren C Wene, Brian W Pogue, Philip L Bailin, Edward V Maytin.   

Abstract

Topical 5-aminolevulinic acid (ALA) is widely used in photodynamic therapy (PDT) of actinic keratoses (AK), a type of premalignant skin lesion. However, the optimal time between ALA application and exposure to light has not been carefully investigated. Our objective is to study the kinetics of protoporphyrin IX (PpIX) accumulation in AK after short contact ALA and relate this to erythemal responses. Using a noninvasive dosimeter, PpIX fluorescence measurements (5 replicates) were taken at 20-min intervals for 2 h following ALA application, in 63 AK in 20 patients. Data were analyzed for maximal fluorescent signal obtained, kinetic slope, and changes in erythema. Our results show that PpIX accumulation was linear over time, becoming statistically higher than background in 48% of all lesions by 20 min, 92% of lesions by 1 h, and 100% of lesions by 2 h. PpIX accumulation was roughly correlated with changes in lesional erythema post-PDT. We conclude that significant amounts of PpIX are produced in all AK lesions by 2 h. The linear kinetics of accumulation suggest that shorter ALA application times may be efficacious in many patients. Noninvasive fluorescence monitoring of PpIX may be useful to delineate areas of high PpIX accumulation within precancerous areas of the skin.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21054081      PMCID: PMC2955723          DOI: 10.1117/1.3484255

Source DB:  PubMed          Journal:  J Biomed Opt        ISSN: 1083-3668            Impact factor:   3.170


  18 in total

1.  Preliminary evaluation of two fluorescence imaging methods for the detection and the delineation of basal cell carcinomas of the skin.

Authors:  S Andersson-Engels; G Canti; R Cubeddu; C Eker; C af Klinteberg; A Pifferi; K Svanberg; S Svanberg; P Taroni; G Valentini; I Wang
Journal:  Lasers Surg Med       Date:  2000       Impact factor: 4.025

2.  Pretreatment photosensitizer dosimetry reduces variation in tumor response.

Authors:  Xiaodong Zhou; Brian W Pogue; Bin Chen; Eugene Demidenko; Rohan Joshi; Jack Hoopes; Tayyaba Hasan
Journal:  Int J Radiat Oncol Biol Phys       Date:  2006-03-15       Impact factor: 7.038

3.  Photodynamic therapy in dermatology: the next five years.

Authors:  Michael H Gold
Journal:  Dermatol Clin       Date:  2007-01       Impact factor: 3.478

4.  Bispectral fluorescence imaging of aggressive basal cell carcinoma combined with histopathological mapping: a preliminary study indicating a possible adjunct to Mohs micrographic surgery.

Authors:  B Stenquist; M B Ericson; C Strandeberg; L Mölne; A Rosén; O Larkö; A M Wennberg
Journal:  Br J Dermatol       Date:  2006-02       Impact factor: 9.302

5.  Fiber-optic bundle design for quantitative fluorescence measurement from tissue.

Authors:  B W Pogue; G Burke
Journal:  Appl Opt       Date:  1998-11-01       Impact factor: 1.980

6.  Can autofluorescence demarcate basal cell carcinoma from normal skin? A comparison with protoporphyrin IX fluorescence.

Authors:  R Na; I M Stender; H C Wulf
Journal:  Acta Derm Venereol       Date:  2001 Aug-Sep       Impact factor: 4.437

7.  Low-dose methotrexate enhances aminolevulinate-based photodynamic therapy in skin carcinoma cells in vitro and in vivo.

Authors:  Sanjay Anand; Golara Honari; Tayyaba Hasan; Paul Elson; Edward V Maytin
Journal:  Clin Cancer Res       Date:  2009-05-15       Impact factor: 12.531

8.  A trial of short incubation, broad-area photodynamic therapy for facial actinic keratoses and diffuse photodamage.

Authors:  Dany Touma; Mina Yaar; Sara Whitehead; Nellie Konnikov; Barbara A Gilchrest
Journal:  Arch Dermatol       Date:  2004-01

Review 9.  Pain associated with aminolevulinic acid-photodynamic therapy of skin disease.

Authors:  Christine B Warren; Laszlo J Karai; Allison Vidimos; Edward V Maytin
Journal:  J Am Acad Dermatol       Date:  2009-12       Impact factor: 11.527

Review 10.  delta-Aminolevulinic acid and blue light photodynamic therapy for treatment of multiple basal cell carcinomas in two patients with nevoid basal cell carcinoma syndrome.

Authors:  Aleksandr Itkin; Barbara A Gilchrest
Journal:  Dermatol Surg       Date:  2004-07       Impact factor: 3.398

View more
  10 in total

1.  Photosensitizer fluorescence and singlet oxygen luminescence as dosimetric predictors of topical 5-aminolevulinic acid photodynamic therapy induced clinical erythema.

Authors:  Srivalleesha Mallidi; Sriram Anbil; Seonkyung Lee; Dieter Manstein; Stefan Elrington; Garuna Kositratna; David Schoenfeld; Brian Pogue; Steven J Davis; Tayyaba Hasan
Journal:  J Biomed Opt       Date:  2014-02       Impact factor: 3.170

2.  Techniques for fluorescence detection of protoporphyrin IX in skin cancers associated with photodynamic therapy.

Authors:  Kishore R Rollakanti; Stephen C Kanick; Scott C Davis; Brian W Pogue; Edward V Maytin
Journal:  Photonics Lasers Med       Date:  2013-11-01

3.  Photodynamic Therapy for Actinic Keratoses of the Upper Extremities using 10% Aminolevulinic Acid Gel, Red Light, and Adapalene Pretreatment.

Authors:  Barry I Galitzer
Journal:  J Clin Aesthet Dermatol       Date:  2021-10

4.  Dual-channel red/blue fluorescence dosimetry with broadband reflectance spectroscopic correction measures protoporphyrin IX production during photodynamic therapy of actinic keratosis.

Authors:  Stephen Chad Kanick; Scott C Davis; Yan Zhao; Tayyaba Hasan; Edward V Maytin; Brian W Pogue; M Shane Chapman
Journal:  J Biomed Opt       Date:  2014       Impact factor: 3.170

5.  Noninvasive Optical Imaging of UV-Induced Squamous Cell Carcinoma in Murine Skin: Studies of Early Tumor Development and Vitamin D Enhancement of Protoporphyrin IX Production.

Authors:  Kishore R Rollakanti; Sanjay Anand; Scott C Davis; Brian W Pogue; Edward V Maytin
Journal:  Photochem Photobiol       Date:  2015-09-25       Impact factor: 3.421

6.  Vitamin D Combined with Aminolevulinate (ALA)-Mediated Photodynamic Therapy (PDT) for Human Psoriasis: A Proof-of-Principle Study.

Authors:  Edward V Maytin; Golara Honari; Amor Khachemoune; Charles R Taylor; Bernhard Ortel; Brian W Pogue; Nathaniel Sznycer-Taub; Tayyaba Hasan
Journal:  Isr J Chem       Date:  2012-08-21       Impact factor: 3.333

7.  A regimen to minimize pain during blue light photodynamic therapy of actinic keratoses: Bilaterally controlled, randomized trial of simultaneous versus conventional illumination.

Authors:  Urvashi Kaw; Muneeb Ilyas; Taylor Bullock; Lisa Rittwage; Margo Riha; Allison Vidimos; Bo Hu; Christine B Warren; Edward V Maytin
Journal:  J Am Acad Dermatol       Date:  2019-09-13       Impact factor: 11.527

8.  Pre-treatment protoporphyrin IX concentration in actinic keratosis lesions may be a predictive biomarker of response to aminolevulinic-acid based photodynamic therapy.

Authors:  S C Kanick; S C Davis; Y Zhao; K L Sheehan; T Hasan; E V Maytin; B W Pogue; M S Chapman
Journal:  Photodiagnosis Photodyn Ther       Date:  2015-10-22       Impact factor: 3.631

9.  Randomized Vehicle-Controlled Study of Short Drug Incubation Aminolevulinic Acid Photodynamic Therapy for Actinic Keratoses of the Face or Scalp.

Authors:  David M Pariser; Anna Houlihan; Mary Beth Ferdon; James E Berg
Journal:  Dermatol Surg       Date:  2016-03       Impact factor: 3.398

10.  Characterization and standardization of tissue-simulating protoporphyrin IX optical phantoms.

Authors:  Mikael Marois; Jaime Bravo; Scott C Davis; Stephen Chad Kanick
Journal:  J Biomed Opt       Date:  2016-03       Impact factor: 3.170

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.